Manatt Health’s analysis of the Graham-Cassidy bill was cited by the New York Times in an article discussing the health insurance industry’s reaction to the proposed legislation. The publication noted that the industry came out forcefully against the bill, suggesting that state-by-state block grants could create healthcare chaos in the short term and uncertainty within the market.
Analyses of the proposal, including Manatt Health’s, show that some states would gain funding under the proposal, while others would see significant reductions. The publication cites Manatt Health’s study, explaining that “states such as Alaska, Connecticut, Delaware, New Hampshire, New Mexico, New York, Oregon, Vermont and Washington would see reductions of 25 percent or more over the 2020 to 2026 period” compared with the funding they would receive under the current law.